Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Am J Med. 2012 Aug 8;125(10):1010–1018. doi: 10.1016/j.amjmed.2012.03.007

Table 6.

Outcomes of patients with venous thromboembolism.*

Chronic obstructive pulmonary disease
Total
(n=2488)
Yes
(n =484)
No
(n = 2004)
p-value
No complications, n (%) 1766 (71.0) 307 (63.4) 1,459 (72.8) <0.0001
Recurrent pulmonary embolism, n (%) 38 (1.5) 6 (1.2) 32 (1.6) 0.56
Recurrent deep vein thrombosis, n (%) 287 (11.5) 65 (13.4) 222 (11.1) 0.15
Long-term major bleeding, n (%) 313 (12.6) 70 (14.5) 243 (12.1) 0.17
In-hospital major bleeding, n (%) 103 (4.1) 25 (5.2) 78 (3.9) 0.22
Hep arin-induced thrombocytopenia, n (%) 25 (1.6) 9 (1.9) 16 (0.8) 0.1
In-hospital death, n (%) 113 (4.5) 33 (6.8) 80 (4) 0.01
Death within 30 days of venous thromboembolism diagnosis, n (%) 191 (8.0) 61 (12.6) 130 (6.5) <0.0001
*

Long-term outcomes data encompassed a median follow-up period of 992 days.